TrialLancet (London, England)2017

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.

Nadine G Rouphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.